QBx (formerly Known As PHI-5, K041059)

QBX (FORMERLY KNOWN AS PHI-5, K041059)- zinc and rubidium cream
Biocellerex, Inc.

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

1-Label_QBX
(click image for full-size original)

INDICATIONS:

QBX (FORMERLY KNOWN AS PHI-5, K041059)
rubidium chloride, zinc chloride cream
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:69801-102
Route of Administration TOPICAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
ZINC (ZINC) ZINC 0.006 g in 100 mL
RUBIDIUM (RUBIDIUM) RUBIDIUM 0.17 g in 100 mL
Inactive Ingredients
Ingredient Name Strength
WATER
ANHYDROUS CITRIC ACID
POTASSIUM CITRATE
CALCIUM CHLORIDE
BENZOIC ACID
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:69801-102-11 10 mL in 1 VIAL None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
unapproved drug other 07/14/2015
Labeler — Biocellerex, Inc. (079715783)

Revised: 07/2015 Biocellerex, Inc.

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2019. All Rights Reserved.